Considering that capsaicin would induce essentially the same disturbances in both humans and animals, NaBPC157 can be used for the treatment of various pain disturbances as well as in conditions followed by somatosensory neuron function impairment
The second is the evidence gap : because the blend has never been trialed as a fixed product, every dose, schedule and timeline here is inference from the two component literatures, not a proven blend outcome
Research use therefore focuses on mechanism, target validation, and combinatorial experiments (e.g., with dietary change or NAD precursors) [14,8,9]
Importantly, these natural polymer nanocarriers align with the clean-label trend in functional foods
Administration method: Subcutaneous injection, once a day, for 8 consecutive weeks
Amylin also suppresses inappropriate postprandial glucagon secretion